FDA Inspection 1100365 — Imrozia Arif, M.D.
The FDA completed an inspection of Imrozia Arif, M.D. on July 12, 2019 in Glasgow. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 12, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Glasgow (United Kingdom)
Additional Details
Clinical Investigator (CI)